Robert E. Gagnon Ocuphire Pharma, Inc. (OCUP) insider trading activity

OCUP Quotes by TradingView

Robert E. Gagnon is Chief Financial Officer of Ocuphire Pharma, Inc.. Currently has a direct ownership of 200,000 shares of OCUP, which is worth approximately $196,000. The most recent transaction as insider was on Sep 10, 2025, when has been sold 200,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 200K
n/a 3M change
n/a 12M change
Total Value Held $196,000

Robert E. Gagnon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 10 2025
BUY
Grant, award, or other acquisition
-
200,000 Added 50.0%
200,000 Common Stock

Also insider at

VSTM
Verastem, Inc. Healthcare
Director
BBLG
Bone Biologics Corp Healthcare
Director
HBIO
HARVARD BIOSCIENCE INC Healthcare
Director
REG

Robert E. Gagnon

Chief Financial Officer
Needham, MA

Track Institutional and Insider Activities on OCUP

Follow Ocuphire Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUP shares.

Notify only if

Insider Trading

Get notified when an Ocuphire Pharma, Inc. insider buys or sells OCUP shares.

Notify only if

News

Receive news related to Ocuphire Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OCUP